Saturday, February 8, 2025

CATEGORY

ISPOR

ISPOR Debuts HEOR Explained to Enhance Healthcare Decision-Making

Key TakeawaysEnhances understanding of HEOR’s impact on healthcare policy and patient care. Provides accessible tools and resources for informed decision-making. Supports the development...

Maximizing Efficiency in Healthcare Innovation: The Transformative Role of NICE Advice

Key TakeawaysEngaging with NICE Advice early can significantly reduce appraisal timelines. Companies benefit from NICE’s expertise in aligning product development with NHS needs. ...

HEOR Scientists Bolster Healthcare Evidence Amid Biopharma Shifts

Key TakeawaysHEOR evidence remains vital for drug reimbursement and market access despite corporate restructuring. Integration of AI and digital tools is enhancing real-world...

ISPOR Publishes Best Practices for Expert Elicitation in Healthcare Decision-Making

Key TakeawaysISPOR’s new report provides best practices for using structured expert elicitation (SEE) to support healthcare decisions. The report compares five key protocols...

COPD Experience Measure Translated and Validated for Catalan and Spanish Patients

Chronic obstructive pulmonary disease (COPD) significantly impacts patients' lives, making the accurate assessment of their healthcare experiences crucial for improving care. The validation and...

ISPOR Celebrates Leaders in Health Economics with 2024 Awards

ISPOR, the global professional society dedicated to health economics and outcomes research (HEOR), has announced the recipients of its prestigious 2024 HEOR Scientific and...

Medicare’s Strategy for Drug Price Negotiations Uncovered

Key TakeawaysStatutory ceiling drug prices significantly influence initial price offers for certain high-cost drugs. Comparative clinical effectiveness and net pricing are paramount in...

ISPOR Europe 2024 Plenaries and Speakers Announced

ISPOR, the leading professional society for Health Economics and Outcomes Research (HEOR), has announced the plenary sessions and speakers for ISPOR Europe 2024. As...

ISPOR Unveils Ambitious Strategic Plan 2030 to Transform Global Healthcare

ISPOR — The Professional Society for Health Economics and Outcomes Research, the leading professional society for Health Economics and Outcomes Research (HEOR), has announced...

Shaping the Future of Health and Well-Being Through Evidence Generation

10 key takeaways from "Shaping the Future of Health and Well-Being Through Evidence Generation":Holistic Focus on Well-Being: The 2024 theme expands healthcare beyond...

Methods for Comparing Uncontrolled Trials with Real-World Data

Key Takeaways:The increasing use of uncontrolled trials with external controls in health technology assessments (HTA) and regulatory decisions necessitates a systematic approach to...

ISPOR and ACCESS Forum Announce Strategic Collaboration for Upcoming Conferences in Barcelona

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR)—and the ACCESS Forum, a leading international community of market and patient access experts, have...

Strategic Plan Unveiled for ISPOR’s Strategic Vision 2030

The Professional Society for Health Economics and Outcomes Research (ISPOR) announced its new Strategic Plan 2030 that presents a bold new vision for the...

ISPOR Examines Quality-Adjusted Life Years and Alternatives in Healthcare Decision-Making

The Professional Society for Health Economics and Outcomes Research (ISPOR) announced the publication of a collection of papers examining the ongoing debate surrounding the...

Health Technology Assessments Enhanced by ISPOR’s New SUITABILITY Checklist for EHR Data

Amid increasing reliance on electronic health records (EHRs) for health technology assessments (HTA), ISPOR has introduced a comprehensive framework to elevate data integrity and...

Latest news